Among CCM patients, using the gating strategy shown in Fig. 1A, the proportion of TLR4+ (CD4+ and CD8+) T cells was found to be significantly higher in CCMSympt patients (Fig. 1B). Here, CD8A is linked to cerebral cavernous malformation.